Fulvia Fanelli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction to: Anti CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the RFolSTOP multicentre Italian study.
Journal: Annals of hematology
Published: April 21, 2025
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study.
Journal: Annals of hematology
Published: November 28, 2024
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
Journal: European journal of haematology
Published: July 23, 2024
Congenital toxoplasmosis and audiological outcome: from a case series to a suggestion of patient-based schedule.
Journal: Frontiers in pediatrics
Published: September 19, 2023
Predicting the profile of increasing disability in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 03, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 25, 2018
Lesion symptom map of cognitive-postural interference in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 25, 2017
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline.
Journal: Journal of the neurological sciences
Published: February 15, 2017
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial.
Journal: CNS drugs
Published: December 21, 2016
A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta.
Journal: Multiple sclerosis and related disorders
Published: February 24, 2016
Long-term assessment of No Evidence of Disease Activity with natalizumab in relapsing multiple sclerosis.
Journal: Journal of the neurological sciences
Published: January 20, 2016
Last Updated: 09/26/2026